You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemotherapy, Neoadjuvant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Female Trial (Pyrotinib and Trastuzumab)

Not yet recruiting
  • Breast Cancer Female
  • Pyrotinib and Trastuzumab
  • (no location specified)
Sep 11, 2023

Resectable Biliary Tract Cancer Trial in Tianjin (Cisplatin, Gemcitabine, Nab-paclitaxel)

Recruiting
  • Resectable Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Nov 30, 2022

Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

Not yet recruiting
  • Stage IIIB(N2) Non-small Cell Lung Cancer
  • +3 more
  • Pembrolizumab 200 mg IV infusion
  • Beijing, Beijing, China
    Peking University
May 30, 2023

Colon Cancer Trial (Neoadjuvant chemo)

Not yet recruiting
  • Colon Cancer
  • Neoadjuvant chemotherapy
  • (no location specified)
Oct 25, 2023

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of

Not yet recruiting
  • Organoids
  • +2 more
  • Biopsy
  • (no location specified)
Nov 24, 2023

Micrometastases in Axillary Lymph Nodes in Breast Cancer,

Completed
  • Micrometastases
  • Neoadjuvant Chemotherapy
  • Sentinel lymph node biopsy, axillary lymph node dissection
  • (no location specified)
Nov 20, 2023

Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

Recruiting
  • Non-Small Cell Lung Cancer
  • Neoadjuvant immunochemotherapy
  • Neoadjuvant chemotherapy
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Aug 1, 2023

Osteosarcoma Trial (Surufatinib plus chemo, Chemotherapy)

Not yet recruiting
  • Osteosarcoma
  • (no location specified)
Jun 29, 2023

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab Trial in Beijing (Pembrolizumab, Cisplatin,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Beijing, Beijing, China
    Beijing Tongren Hospital
Oct 26, 2023

Breast Cancer, Chemo Effect Trial (Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel, Epirubicin, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
  • Epirubicin, Cyclophosphamide, Docetaxel
  • (no location specified)
Jun 21, 2023

Surgery After Neoadjuvant Chemotherapy in Locally Advanced

Completed
  • Postoperative Complications
  • surgery after neoadjuvant chemotherapy
  • Seoul, Korea, Republic of
    Asan medical center
Jun 1, 2023

Sentinel Lymph Node Trial (sentinle lymphnode biopsy)

Not yet recruiting
  • Sentinel Lymph Node
  • sentinle lymphnode biopsy
  • (no location specified)
Nov 11, 2023

Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)

Not yet recruiting
  • Inflammatory Breast Cancer
  • Breast conserving surgery
  • Radical modified mastectomy
  • (no location specified)
Nov 14, 2023

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Apr 2, 2023

Anemia Trial in Philadelphia (Venofer)

Recruiting
  • Anemia
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 24, 2023

Rectal Cancer Trial in Osaka (radiation, drug, procedure)

Recruiting
  • Rectal Cancer
  • Radiation
  • +2 more
  • Osaka, Japan
  • +1 more
Jul 1, 2023

TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Camrelizumab Plus Chemotherapy and Famitinib
  • Camrelizumab Plus Chemotherapy
  • (no location specified)
Aug 17, 2023

Breast Cancer Trial (Arm I (No PMRT), Arm II (PMRT))

Not yet recruiting
  • Breast Cancer
  • Arm I (No PMRT)
  • Arm II (PMRT)
  • (no location specified)
Aug 8, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Chemoimmunotherapy
  • neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
  • (no location specified)
Feb 14, 2023

Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)

Recruiting
  • Breast Cancer
  • Shijiazhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Oct 25, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Female Breast Cancer Trial in Sohag (Hormonal Antineoplastics, Chemotherapy drug)

Not yet recruiting
  • Female Breast Cancer
  • Hormonal Antineoplastics
  • Chemotherapy drug
  • Sohag, Egypt
    amal Ali
Feb 23, 2023